gip glp 1 agonist tirzepatide Understand GLP-1/GIP Dual and Its Effect on Current Weight Loss Therapy Tirzepatide, a dual GIP/GLP-1 receptor

Curious about switching from Mounjaro to Wegovy

In a placebo-controlled randomized trial, adults with obesity and alcohol use disorder had a greater drop in heavy drinking days with semaglutide

Enjoy the holiday feast without feeling sluggish afterwards.

Firm Novo Nordisks global patent is set to expire in parts of the world from early 2026, allowing cut-price own-label versions of Wegovy and Ozempic to be sold, according to reports

Looking forward to chatting with Alice Tracey of The Capitol Forum on GLP-1 compounding next Tuesday!

A product liability lawsuit claims Ozempic side effects caused a woman's internal organs to become inflamed, resulting in the need for gallbladder removal surgery.